Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents
The information in the brief version is excerpted directly from the full-text guidelines. The brief version is a compilation of the tables and boxed recommendations.
Last Updated: October 18, 2017; Last Reviewed: October 18, 2017
Treating Mucosal Candidiasis
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Esophageal candidiasis (Duration of Therapy: 14–21 days)
Note: A higher rate of esophageal candidiasis relapse has been reported with echinocandins than with fluconazole.
Uncomplicated Vulvovaginal Candidiasis
Note: Severe or recurrent vaginitis should be treated with oral fluconazole (100–200 mg) or topical antifungals for ≥7 days (AII)
Chronic Suppressive Therapy
If Decision Is To Use Suppressive Therapy
Key to Acronyms: ARV = antiretroviral; BID = twice daily; CD4 = CD4 T lymphocyte; IV = intravenous; OI = opportunistic infection; PO = orally; QID = four times daily
- CDC | 2015 STD Treatment Guidelines
- HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C
- AIDSinfo Patient Materials: What is an Opportunistic Infection?
- AIDSource | HIV-Related Conditions
- AETC National HIV Curriculum
- How to Cite These Guidelines
- Adult and Adolescent OI Guidelines Archive